Considerations for Dose adjustment of Sublingual Tacrolimus from Oral Tacrolimus ~50 % of oral dose ( because with SL dose you will bypass the CYP3 metabolism in the GI tract as well as effusion by P-Glycoproteins ) #astfellows2020

Tweet 4 (Testing methods): 🔬 How labs detect it: •ELISA: Sensitive but less specific → false positives possible •Crithidia luciliae IFA: Very specific, less sensitive •Farr radioimmunoassay: Gold-standard specificity, quantitative, rarely available

2025 Update on resistant hypertension in CKD: where do we stand and where do we go? 🔓doi.org/10.1093/ckj/sf…

NEW Chapter 👉Thrombotic Microangiopathy by Dr. Nattawat Klomjit, Dr. Paolo So, Dr. Jean Hou, Dr. Anuja Java Access the chapter here: bit.ly/ThromboticMicr… Paolo Nikolai So Jean Hou, MD Anuja Java, MD (she/her) #GlomPedia #GlomCon

Today's Nobel Prize for Physiology or Medicine relates to research on regulatory T cells nobelprize.org/prizes/medicin… For readers interested in harnessing the biology of regulatory T cells to treat disease, here's a comprehensive review nature.com/articles/s4157… rdcu.be/eJHU8

💊 ¿Sabías que no todos los antagonistas del Rc de mineralocorticoide son iguales? 💥Espironolactona: eficaz pero hormonalmente dramática 💥Eplerenona: más suave. 💥Finerenona: modesto en PA, estrella en protección renal 🌟 👇👇👇 revistanefrologia.com/es-finerenona-… S.E.N. Nefrología Sociedad Madrileña de Nefrología (SOMANE)

#Glucocorticoid treatment has become the most common drug-induced form of #osteoporosis because of its broad therapeutic use for various inflammatory and haematological diseases and its pivotal role in transplantation medicine thelancet.com/journals/landi… #OpenAccess

Pathogenesis of #IgAN and emerging targets 🎯 ca. 2025 from NDT #RKDSummit #Nephpearls 👉🏼 pubmed.ncbi.nlm.nih.gov/40796290/

Las mejores IAs para Optimizar la Investigación Académica 👇

Hyperkalemia risk of finerenone versus spironolactone in CKD patients with type 2 diabetes doi.org/10.1093/ndt/gf… ➡️In this study of patients with T2DM and CKD, finerenone is associated with less hyperkalemia risk than spironolactone

Gout Management in Patients With CKD: A Review ca. 2025 from AJKD #Nephpearls 👉 pubmed.ncbi.nlm.nih.gov/40609855/

🧠 “Challenges in ANCA-Associated Vasculitis (AAV): Diagnosis, Classification & Prognosis” — Key points !! 🔹 AAV = 3 intertwined diseases: GPA 🩸 | MPA 🧬 | EGPA 🫁 — overlapping but distinct by organ pattern + ANCA specificity (PR3 vs MPO). 🔹 Diagnosis dilemma: No gold

⚡EULAR 2025 Update: Lupus Nephritis (SLE Kidney Involvement) 1️⃣ New Structure: 4 principles + 13 recommendations (evidence-graded). 2️⃣ Core Approach: 🔹 Early biopsy, expert care, & HCQ for all. 🔹 Rheumatology–nephrology team care. 🔹 Aim: prevent CKD, reduce flares, improve

Muy buena imagen donde representa los años ganados con la implementación de ARA2, iSGLT2, nsMRA Y GLP1-RA en ERC Para las diapositivas 💊💊💊💊👏🏻👏🏻👇🏻 NDT

Membranous nephropathy treatment standard 🆓doi.org/10.1093/ndt/gf…

🤩Update on KDIGO guidelines on IgA Nephropathy academic.oup.com/ckj/advance-ar… CKJ

⚠️Escenarios clínicos donde los ACOD no deben indicarse. ✍️🏻🚫💊 🔶️Los ACOD (apixabán, rivaroxabán, dabigatrán y edoxabán) han reemplazado en gran medida a los AVK (warfarina, acenocumarol) para la FA y la TVP/TEP, gracias a su eficacia similar y menor riesgo de sangrado

💊Resistant Hypertension in CKD Management academic.oup.com/ckj/advance-ar… CKJ

NEW Chapter 👉Minimal Change Disease at glompedia.org Minimal Change Disease is a podocytopathy appearing normal on light microscopy and immunofluorescence. Electron microscopy reveals the diagnostic feature: diffuse podocyte foot process effacement. Read more:

Muy buena imagen de clasificación actual de anticuerpos monoclonales 👌🏻👌🏻👌🏻